Breaking News Instant updates and real-time market news.

2021-01-13 14:38:17 STWRY Software AG $0.00 / + (+0.00%) 14:38 01/13/21 01/13 14:38 01/13/21 14:38	Software AG price target lowered to EUR 35 from EUR 37 at JPMorgan JPMorgan analyst Stacy Pollard lowered the firm's price target on Software AG to EUR 35 from EUR 37 and keeps a Neutral rating on the shares.
STWRY Software AG $0.00 / + (+0.00%) 12/14/20 Societe Generale Software AG price target lowered to EUR 30 from EUR 32 at Societe Generale 12/11/20 Societe Generale Software AG price target lowered to EUR 30 from EUR 32 at Societe Generale 12/08/20 Kepler Cheuvreux Software AG downgraded to Hold from Buy at Kepler Cheuvreux 10/23/20 Deutsche Bank Software AG price target lowered to EUR 33 from EUR 36 at Deutsche Bank

2021-01-13 14:38:17

STWRY

Software AG

$0.00 / + (+0.00%)

14:38

01/13/21

01/13

14:38

01/13/21

14:38

Software AG price target lowered to EUR 35 from EUR 37 at JPMorgan

JPMorgan analyst Stacy Pollard lowered the firm's price target on Software AG to EUR 35 from EUR 37 and keeps a Neutral rating on the shares.

STWRY Software AG

$0.00 / + (+0.00%)

12/14/20 Societe Generale: Software AG price target lowered to EUR 30 from EUR 32 at Societe Generale

12/11/20 Societe Generale: Software AG price target lowered to EUR 30 from EUR 32 at Societe Generale

12/08/20 Kepler Cheuvreux: Software AG downgraded to Hold from Buy at Kepler Cheuvreux

10/23/20 Deutsche Bank: Software AG price target lowered to EUR 33 from EUR 36 at Deutsche Bank

TODAY'S FREE FLY STORIES

Initiation	LoanDepot initiated with a Neutral at Goldman Sachs » 05:02 03/08/21 03/08 05:02 03/08/21 05:02 LDI LoanDepot $18.55 / +0.33 (+1.81%) , RKT Rocket Companies $25.07 / -1.7801 (-6.63%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options LDI RKT LDI LoanDepot $18.55 / +0.33 (+1.81%) 02/18/21 loanDepot rises 10.9% 02/16/21 loanDepot falls -14.0% 02/12/21 loanDepot rises 38.6% 02/12/21 loanDepot rises 21.4% RKT Rocket Companies $25.07 / -1.7801 (-6.63%) 03/04/21 Tanger Factory up 25% in pre-market trading amid WallStreetBets mentions 03/04/21 Tanger Factory is today's Rocket with 32% short position, Jim Cramer says 03/03/21 Rocket Companies falls -19.6% 03/03/21 Rocket Companies falls -17.5% LDI RKT LDI LoanDepot $18.55 / +0.33 (+1.81%) RKT Rocket Companies $25.07 / -1.7801 (-6.63%) 03/03/21 Fly Intel: Top five analyst downgrades 03/03/21 Zelman Rocket Companies downgraded to Hold from Buy at Zelman 03/02/21 RBC Capital Rocket Companies downgraded to Sector Perform from Outperform at RBC Capital 03/02/21 Wells Fargo Wells says Rocket Companies Q4 results 'not good enough to support' today's move RKT RKT Rocket Companies $25.07 / -1.7801 (-6.63%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 11 Feb 06 Aug RKT RKT Rocket Companies $25.07 / -1.7801 (-6.63%) 03/05/21 UWM CEO accuses Rocket Companies of stifling mortgage brokers, DFP reports 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports LDI RKT LDI LoanDepot $18.55 / +0.33 (+1.81%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 01/31/21 Opening Day: Qualtrics jumps 40% in trading debut RKT Rocket Companies $25.07 / -1.7801 (-6.63%) 03/03/21 Rocket slides as analyst cuts rating following Reddit-fueled rally 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers RKT RKT Rocket Companies $25.07 / -1.7801 (-6.63%) 03/04/21 Notable open interest changes for March 4th 03/03/21 Notable open interest changes for March 3rd 03/03/21 Unusual call flow in option market yesterday 03/02/21 Callapalozza in Rocket Mortage echoes Gamestop squeeze
Initiation	Bioventus initiated with a Buy at Goldman Sachs » 05:00 03/08/21 03/08 05:00 03/08/21 05:00 BVS Bioventus $11.50 / -0.48 (-4.01%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Syndicate On The Fly Events 11 Feb BVS Bioventus $11.50 / -0.48 (-4.01%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts 03/25/21 Bioventus - BVS
Initiation	Bumble initiated with a Market Perform at BMO Capital » 04:59 03/08/21 03/08 04:59 03/08/21 04:59 BMBL Bumble $61.93 / +2.41 (+4.05%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly Events Options BMBL Bumble $61.93 / +2.41 (+4.05%) 03/04/21 Fly Intel: Top five analyst initiations 03/04/21 Susquehanna Bumble initiated with a Positive, $78 price target at Susquehanna 03/04/21 Susquehanna Bumble initiated with a Positive at Susquehanna 03/02/21 Benchmark Benchmark sees 'hidden asset' inside Momo, ups target to $32 11 Feb BMBL Bumble $61.93 / +2.41 (+4.05%) 03/04/21 Snowflake, Qualcomm upgrades among today's top calls on Wall Street 02/14/21 Opening Day: Bumble, Viant soar in market debuts 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 03/10/21 Bumble - BMBL BMBL Bumble $61.93 / +2.41 (+4.05%) 02/18/21 Fourteen new option listings and one option delisting on February 18th
Initiation	Nuvation Bio initiated with an Outperform at BMO Capital » 04:57 03/08/21 03/08 04:57 03/08/21 04:57 NUVB Nuvation Bio $10.86 / +0.36 (+3.43%) BMO Capital analyst Do… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Upgrade	Marvell upgraded to Outperform from Market Perform at BMO Capital » 04:56 03/08/21 03/08 04:56 03/08/21 04:56 MRVL Marvell $41.51 / +1.41 (+3.52%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MRVL Marvell $41.51 / +1.41 (+3.52%) 03/03/21 Marvell CEO says 'ended fiscal year 2021 on a strong note' 03/03/21 Marvell reports Q4 adjusted gross margin 63.9% 02/25/21 Marvell, Fujitsu partner on 5G baseband technology 02/18/21 Marvell's storage solutions included in Toshiba's new 18TB hard disk drive MRVL Marvell $41.51 / +1.41 (+3.52%) 03/04/21 Jefferies Marvell long-term visibility better than previously thought, says Jefferies 03/02/21 Susquehanna Marvell results expected to be a modest beat, says Susquehanna 02/16/21 Needham Inphi price target raised to $191 from $175 at Needham 02/09/21 Barclays Inphi downgraded to Equal Weight on Marvell deal at Barclays MRVL Marvell $41.51 / +1.41 (+3.52%) 03/03/21 Marvell sees Q1 adjusted EPS 23c-31c, consensus 27c 03/03/21 Marvell reports Q4 adjusted EPS 29c, consensus 29c 12/03/20 Marvell sees Q4 adjusted EPS 25c-33c, consensus 29c 12/03/20 Marvell reports Q3 adjusted EPS 25c, consensus 25c MRVL Marvell $41.51 / +1.41 (+3.52%) 10/29/20 Marvell near deal to acquire Inphi for about $10B, WSJ reports MRVL Marvell $41.51 / +1.41 (+3.52%) 03/04/21 Fly Intel: Pre-market Movers 03/03/21 Fly Intel: After-Hours Movers 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Fly Insider:180 Degree Capital, AMC among week's notable insider trades MRVL Marvell $41.51 / +1.41 (+3.52%) 03/03/21 Marvell options imply 10.5% move in share price post-earnings 12/21/20 Unusual call flow in option market yesterday 12/18/20 Call Seller in Marvell exits Dec trade for 97% loss 12/17/20 Marvell call volume above normal and directionally bullish

General news	3-Month Bill Auction to be released at 11:30 04:55 03/08/21 03/08 04:55 03/08/21 04:55
General news	6-Month Bill Auction to be released at 11:30 04:55 03/08/21 03/08 04:55 03/08/21 04:55
Conference/Events	Atlassian management to meet virtually with Mizuho » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 TEAM Atlassian $228.22 / +2.865 (+1.27%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TEAM Atlassian $228.22 / +2.865 (+1.27%) 02/26/21 Atlassian acquires Chartio, terms not disclosed 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 11/16/20 Lone Pine buys Square, exits Visa in Q3 TEAM Atlassian $228.22 / +2.865 (+1.27%) 03/03/21 Citi Atlassian assumed with a Buy at Citi 01/29/21 DA Davidson Atlassian price target raised to $275 from $235 at DA Davidson 01/29/21 BMO Capital Atlassian price target raised to $260 from $235 at BMO Capital 01/29/21 Canaccord Atlassian price target raised to $260 from $225 at Canaccord TEAM Atlassian $228.22 / +2.865 (+1.27%) 01/28/21 Atlassian reports Q2 EPS 37c, consensus 32c 10/29/20 Atlassian sees Q2 EPS 30c-32c, consensus 33c 10/29/20 Atlassian sees Q2 EPS 30c-32c, consensus 33c 10/29/20 Atlassian reports Q1 EPS (9c) incl. non-cash charge, consensus 27c TEAM Atlassian $228.22 / +2.865 (+1.27%) 01/28/21 Fly Intel: After-Hours Movers 10/30/20 Fly Intel: Wall Street's top stories for Friday 10/30/20 Fly Intel: Wall Street's top stories at midday 10/29/20 Fly Intel: After-Hours Movers 00:00 Today Atlassian 03/11/21 Atlassian TEAM Atlassian $228.22 / +2.865 (+1.27%) 02/23/21 Atlassian call volume above normal and directionally bullish 02/22/21 Atlassian March 290 calls see heavy volume as shares dip 01/28/21 Atlassian options imply 11.5% move in share price post-earnings 12/21/20 Atlassian call volume above normal and directionally bullish
Conference/Events	Oppenheimer healthcare analysts hold an analyst/industry conference call » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 Healthcare Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Conference/Events	Jamf Holding management to meet virtually with Mizuho » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 JAMF Jamf Holding $35.02 / -1.435 (-3.94%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events JAMF Jamf Holding $35.02 / -1.435 (-3.94%) 03/01/21 Jamf acquires security, compliance solutions created by cmdSecurity 02/01/21 Jamf Holding COO, CFO sell 60.7K shares and 6.3K shares in common stock 01/04/21 Jamf Holding announces it is running on more than 20M Apple devices 11/16/20 Tiger Global adds Snowflake, GSX and BigCommerce during Q3 JAMF Jamf Holding $35.02 / -1.435 (-3.94%) 03/05/21 RBC Capital Jamf Holding price target raised to $49 from $45 at RBC Capital 03/05/21 Mizuho Jamf Holding price target raised to $45 from $43 at Mizuho 01/28/21 Piper Sandler Jamf Holding remains a top idea for 2021 at Piper Sandler 01/05/21 Canaccord Jamf Holding metrics 'bode well' for strong Q4, says Canaccord JAMF Jamf Holding $35.02 / -1.435 (-3.94%) 03/04/21 Jamf Holding sees FY21 revenue $330M-$336M, consensus $316.41M 03/04/21 Jamf Holding sees Q1 revenue $76M-$77M, consensus $72.44M 03/04/21 Jamf Holding reports Q4 EPS (8c), consensus 1c 19 Nov 22 Jul JAMF Jamf Holding $35.02 / -1.435 (-3.94%) 03/04/21 Fly Intel: After-Hours Movers 00:00 Today Jamf Holding

Conference/Events	Amicus participates in a conference call with JPMorgan » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 FOLD Amicus $10.50 / +0.15 (+1.45%) SMid Cap Biotech Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FOLD Amicus $10.50 / +0.15 (+1.45%) 03/01/21 Amicus sees FY21 total Galafold revenue $300M-$315M 02/11/21 Amicus AT-GAA not stat. significant for superiority vs. alglucosidasa alfa 02/11/21 Amicus trading resumes 02/11/21 Amicus trading halted, news pending FOLD Amicus $10.50 / +0.15 (+1.45%) 03/01/21 Stifel Amicus initiated with a Hold at Stifel 02/12/21 Fly Intel: Top five analyst downgrades 02/12/21 JPMorgan Amicus downgraded to Neutral on Pompe disease miss at JPMorgan 02/12/21 SVB Leerink Amicus downgraded to Market Perform from Outperform at SVB Leerink FOLD Amicus $10.50 / +0.15 (+1.45%) 03/01/21 Amicus reports FY20 EPS ($1.07), consensus ($1.02) 11/05/20 Amicus reports Q3 EPS (25c), consensus (22c) FOLD Amicus $10.50 / +0.15 (+1.45%) 02/02/21 Amicus, BioMarin speculated by Dealreporter as possible Vertex targets 10/16/20 Amicus 'a name to watch' if Vertex seeks M&A, Dealreporter says FOLD Amicus $10.50 / +0.15 (+1.45%) 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Fly Intel: After-Hours Movers 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10:00 Today Amicus - FOLD FOLD Amicus $10.50 / +0.15 (+1.45%) 02/11/21 Amicus put volume heavy and directionally bearish 02/03/21 Amicus call volume above normal and directionally bullish
Conference/Events	Ritchie Bros. management to meet virtually with Barrington » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 RBA Ritchie Bros. $54.35 / +3.2 (+6.26%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events RBA Ritchie Bros. $54.35 / +3.2 (+6.26%) 02/08/21 Ritchie Bros. President, International, Karl Werner, departing March 31 RBA Ritchie Bros. $54.35 / +3.2 (+6.26%) 02/24/21 Fly Intel: Top five analyst upgrades 02/24/21 National Bank Ritchie Bros. upgraded to Outperform from Sector Perform at National Bank 02/04/21 BofA Ritchie Bros. downgraded to Underperform on cyclical headwinds at BofA 02/04/21 BofA Ritchie Bros. downgraded to Underperform from Neutral at BofA RBA Ritchie Bros. $54.35 / +3.2 (+6.26%) 02/18/21 Ritchie Bros. reports Q4 EPS 49c, consensus 56c 00:00 Today Ritchie Bros.
Conference/Events	Ideaya Biosciences management to meet virtually with Wedbush » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 IDYA Ideaya Biosciences $19.95 / +0.99 (+5.22%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events IDYA Ideaya Biosciences $19.95 / +0.99 (+5.22%) 02/08/21 Ideaya Biosciences' IND for IDE397 in cancer cleared by FDA 01/19/21 Ideaya Biosciences, Spelman College partner in female African American education 01/11/21 Ideaya Biosciences submits IND application to FDA for intiaition of IDE397 trial 01/05/21 Ideaya Biosciences announces first patient dosed in study of IDE196, crizotinib IDYA Ideaya Biosciences $19.95 / +0.99 (+5.22%) 01/29/21 Baird Ideaya Biosciences assumed at Outperform at Baird 01/06/21 Northland Ideaya Biosciences named a top pick in small cap biotech at Northland 01/05/21 Roth Capital Ideaya combo trial opens up large opportunity, says Roth Capital 10/06/20 Wedbush Wedbush starts Ideaya Biosciences at Outperform with $21 price target IDYA Ideaya Biosciences $19.95 / +0.99 (+5.22%) 11/12/20 Ideaya Biosciences reports Q3 EPS (17c) vs. (54c) last year 18 Jun 03/16/21 31st Annual Healthcare Virtual Conference 00:00 Today Ideaya Biosciences 04/20/21 IDEAYA Biosciences, Inc.
General news	Wholesale Inventories (Preliminary) Month over Month to be reported at 10:00 » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 January Wholesale… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Conference/Events	Silvergate Capital management to meet virtually with Compass Point » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 SI Silvergate Capital $106.63 / -11.01 (-9.36%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SI Silvergate Capital $106.63 / -11.01 (-9.36%) 02/23/21 Silvergate Capital falls -29.2% 01/21/21 Silvergate Capital falls -13.6% 01/15/21 Silvergate Capital falls -6.9% 01/11/21 Silvergate Capital falls -12.8% SI Silvergate Capital $106.63 / -11.01 (-9.36%) 03/02/21 Wedbush Silvergate Capital price target raised to $175 from $150 at Wedbush 02/04/21 Craig-Hallum Silvergate Capital price target raised to $135 from $80 at Craig-Hallum 01/25/21 Canaccord Silvergate Capital price target raised to $90 from $40 at Canaccord 01/25/21 Barclays Silvergate Capital price target raised to $85 from $76 at Barclays SI Silvergate Capital $106.63 / -11.01 (-9.36%) 01/20/21 Silvergate Capital reports Q4 EPS 47c, consensus 38c 10/26/20 Silvergate Capital reports Q3 EPS 37c, consensus 22c 10/26/20 Silvergate Capital reports Q3 EPS 37c, consensus 22c 22 Jan SI Silvergate Capital $106.63 / -11.01 (-9.36%) 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names SI Silvergate Capital $106.63 / -11.01 (-9.36%) 12/22/20 Fly Intel: Pre-market Movers 00:00 Today Silvergate Capital SI Silvergate Capital $106.63 / -11.01 (-9.36%) 01/13/21 Thirteen new option listings and two option delistings on January 13th

Conference/Events	Prestige Consumer management to meet virtually with Sidoti » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 PBH Prestige Consumer $43.52 / +0.93 (+2.18%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PBH Prestige Consumer $43.52 / +0.93 (+2.18%) 01/29/21 Prestige Consumer to replace Foundation Building Materials in S&P 600 on 1/29 01/29/21 Staar Surgical to replace Prestige Consumer in S&P 400 at open on 1/29 01/25/21 Prestige Consumer to replace Foundation Building Materials in S&P 600 on 1/29 01/25/21 Staar Surgical to replace Prestige Consumer in S&P 400 at open on 1/29 PBH Prestige Consumer $43.52 / +0.93 (+2.18%) 08/07/20 DA Davidson Prestige Consumer downgraded to Neutral from Buy at DA Davidson 08/07/20 DA Davidson Prestige Consumer downgraded to Neutral from Buy at DA Davidson 06/29/20 Sidoti Prestige Consumer upgraded to Buy from Neutral at Sidoti 04/15/20 DA Davidson Prestige Consumer price target raised to $47 from $43 at DA Davidson PBH Prestige Consumer $43.52 / +0.93 (+2.18%) 02/04/21 Prestige Consumer raises FY21 adjusted EPS view to approximately $3.22 02/04/21 Prestige Consumer reports Q3 EPS 81c, consensus 77c 11/05/20 Prestige Consumer sees FY21 adjusted EPS $3.18, consensus $3.17 11/05/20 Prestige Consumer reports Q3 non-GAAP EPS 78c, consensus 72c 00:00 Today Prestige Consumer
Conference/Events	InfuSystem participates in a conference call hosted by Lake Street » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 INFU InfuSystem $17.40 / +0.07 (+0.40%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events INFU InfuSystem $17.40 / +0.07 (+0.40%) 02/03/21 InfuSystem acquires FilAMed, terms not disclosed INFU InfuSystem $17.40 / +0.07 (+0.40%) 12/29/20 Sidoti InfuSystem initiated with a Buy at Sidoti 08/31/20 Fly Intel: Top five analyst initiations 08/31/20 Craig-Hallum InfuSystem initiated with a Buy at Craig-Hallum 06/09/20 Lake Street InfuSystem initiated with a Buy at Lake Street INFU InfuSystem $17.40 / +0.07 (+0.40%) 12/15/20 InfuSystem sees FY21 revenue $107M-$110M, consensus $106.4M 11/12/20 InfuSystem sees 2020 revenue $96M-$97M, consensus $96.05M 11/12/20 InfuSystem reports Q3 EPS 14c, consensus 3c 00:00 Today InfuSystem - INFU
Conference/Events	James River Group management to meet virtually with JMP Securities » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 JRVR James River Group $46.83 / -0.19 (-0.40%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options JRVR James River Group $46.83 / -0.19 (-0.40%) 02/17/21 James River Group sees 2020 adjusted net operating income $18M-$22M 10/28/20 James River Group CEO J. Adam Abram to step down, Frank D'Orazio to succeed JRVR James River Group $46.83 / -0.19 (-0.40%) 01/06/21 Compass Point James River Group price target raised to $69 from $56 at Compass Point 11/02/20 Compass Point James River Group upgraded to Buy from Neutral at Compass Point 10/29/20 B. Riley Securities James River Group price target raised to $65 from $60 at B. Riley Securities 09/18/20 Compass Point Compass Point starts James River Group at Neutral amid transition JRVR James River Group $46.83 / -0.19 (-0.40%) 10/28/20 James River Group reports Q3 adj. EPS 56c, consensus 46c 00:00 Today James River Group JRVR James River Group $46.83 / -0.19 (-0.40%) 11/11/20 Three new option listings and one option delisting on November 11th
Conference/Events	Itron management to meet virtually with Stephens » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 ITRI Itron $110.62 / -4.345 (-3.78%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ITRI Itron $110.62 / -4.345 (-3.78%) 02/17/21 Bsquare, Itron extend pact over industrial IoT innovation 01/19/21 Itron and Versant Power collaborate to modernize electricity grid in Maine 10/05/20 ON Semiconductor appoints Itron CEO Thomas Deitrich to board 10/05/20 Itron, Con Ed confirm, NYS affirmed its consent approval for Itron ERT module ITRI Itron $110.62 / -4.345 (-3.78%) 03/03/21 Argus Itron upgraded to Buy from Hold at Argus 03/03/21 Argus Itron upgraded to Buy from Hold at Argus 02/25/21 Oppenheimer Itron price target raised to $127 from $75 at Oppenheimer 01/08/21 Raymond James Itron downgraded to Outperform from Strong Buy at Raymond James ITRI Itron $110.62 / -4.345 (-3.78%) 02/24/21 Itron sees FY21 EPS $2.15-$2.55, consensus $2.26 02/24/21 Itron reports Q4 EPS 65c, consensus 30c 11/02/20 Itron reports Q3 EPS 61c, consensus 25c 00:00 Today Itron
Conference/Events	Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 ADVM Adverum Biotechnologies $11.12 / +0.13 (+1.18%) , UBX Unity Biotechnology $6.17 / -0.58 (-8.59%) , AGTC Applied Genetic $4.89 / -0.16 (-3.17%) , JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) , MGTX MeiraGTx $14.54 / +0.6 (+4.30%) , NITE Nightstar Therapeutics $25.41 / + (+0.00%) , BIIB Biogen $270.57 / +7.08 (+2.69%) , AERI Aerie Pharmaceuticals $18.78 / -0.42 (-2.19%) , ALDX Aldeyra $11.17 / +0.01 (+0.09%) Biopharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Rumors Options ADVM UBX AGTC JNJ MGTX BIIB AERI ALDX ADVM Adverum Biotechnologies $11.12 / +0.13 (+1.18%) 03/01/21 Adverum Biotechnologies provides update on ADVM-022 clinical development path 02/22/21 Adverum appoints Reed Tuckson to board of directors 02/02/21 Adverum announces publication of safety data on ADVM-022 gene therapy 01/11/21 Adverum Biotechnologies announces 2021 focus areas UBX Unity Biotechnology $6.17 / -0.58 (-8.59%) 02/24/21 Unity Biotechnology reports granting of employment inducement awards 02/08/21 Unity Biotechnology's UBX1325 shows eye disease treatment potential in study 02/03/21 Unity Biotechnology reports granting of employment inducement awards 02/01/21 Unity Biotechnology appoints Mike Sapieha as Chief Scientific Advisor AGTC Applied Genetic $4.89 / -0.16 (-3.17%) 02/11/21 Applied Genetic expects cash, cash equivalents to fund programs into 2023 11/11/20 Applied Genetic reports additional data from Phase 1/2 trial in XLRP 10/07/20 Applied Genetic joins My Retina Tracker program as scientific collaborator 09/09/20 Applied Genetic on track for data readouts for ACHM program in Q4 JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 03/05/21 Health Canada authorizes Janssen COVID-19 vaccine 03/04/21 Nemaura Medical appoints Alistair Longmuir as advisor on manufacture strategy 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine 02/28/21 Fly Intel: Top five weekend stock stories MGTX MeiraGTx $14.54 / +0.6 (+4.30%) 01/26/21 MeiraGTx granted fast track designation for AAV-CNGA3 11/13/20 MeiraGTx gene therapy demonstrates improvement in XLRP 10/04/20 MeiraGTx announces 9-month data from Phase 1/2 Trial of AAV-RPGR BIIB Biogen $270.57 / +7.08 (+2.69%) 03/04/21 Biogen to build gene therapy manufacturing center in North Carolina 03/04/21 Dyne Therapeutics appoints Wildon Farwell as CMO 02/03/21 Biogen sees FY21 adjusted R&D expense $2.35B-$2.45B 02/03/21 Biogen CEO sees 'a financial reset in 2021' AERI Aerie Pharmaceuticals $18.78 / -0.42 (-2.19%) 01/11/21 Aerie Pharmaceuticals receives EC marketing approval for Roclanda 11/13/20 Aerie Pharmaceuticals' Roclanda receives positive CHMP opinion in the EU 10/29/20 Aerie Pharmaceuticals initiates Phase 2b trial AR-15512 10/28/20 Aerie, Santen enter exclusive agreement for Rhopressa and Rocklatan in Japan ALDX Aldeyra $11.17 / +0.01 (+0.09%) 02/04/21 Aldeyra announces Phase 3 TRANQUILITY dry eye disease trial design 01/21/21 Aldeyra rises 6% after 1.37M share purchase disclosed by Perceptive Advisors 01/07/21 Aldeyra announces top-line results from run-in cohort in Tranquility study 12/22/20 Aldeyra confirms SARS-CoV-2 antiviral activity of ADX-1612 ADVM UBX AGTC JNJ MGTX NITE BIIB AERI ALDX ADVM Adverum Biotechnologies $11.12 / +0.13 (+1.18%) 12/15/20 UBS Adverum Biotechnologies initiated with a Neutral at UBS 11/15/20 Piper Sandler Adverum Biotechnologies shares should grind higher over time, says Piper Sandler 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform at Raymond James UBX Unity Biotechnology $6.17 / -0.58 (-8.59%) 02/16/21 Citi Unity Biotechnology downgraded to Sell from Neutral at Citi 08/18/20 Fly Intel: Top five analyst downgrades 08/18/20 Morgan Stanley Unity Biotechnology downgraded at Morgan Stanley as UBX101 doesn't meet endpoint 08/18/20 Citi Unity Biotechnology downgraded to Neutral from Buy at Citi AGTC Applied Genetic $4.89 / -0.16 (-3.17%) 03/01/21 Stifel Applied Genetic initiated with a Buy at Stifel 02/02/21 H.C. Wainwright Applied Genetic price target raised to $24 from $18 at H.C. Wainwright 02/01/21 Roth Capital Applied Genetic price target raised to $35 from $30 at Roth Capital 11/17/20 Roth Capital Applied Genetic price target raised to $30 from $26 at Roth Capital JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MGTX MeiraGTx $14.54 / +0.6 (+4.30%) 02/16/21 Chardan MeiraGTx called a Top Pick for 2021 at Chardan 12/17/20 Chardan Chardan boosts MeiraGTx target to $55, say buy shares 'now' 12/17/20 Piper Sandler Piper says MeiraGTx not getting credit for RIX gene therapy that 'clearly works' 10/22/20 RBC Capital MeiraGTx initiated with an Outperform at RBC Capital NITE Nightstar Therapeutics $25.41 / + (+0.00%) BIIB Biogen $270.57 / +7.08 (+2.69%) 02/17/21 Cantor Fitzgerald Biogen price target lowered to $268 from $278 at Cantor Fitzgerald 02/08/21 Citi Expert sees Biogen aducanumab approval 50/50 at best, says Citi 02/04/21 SVB Leerink Biogen price target lowered to $380 from $430 at SVB Leerink 02/04/21 Credit Suisse Biogen price target lowered to $338 from $350 at Credit Suisse AERI Aerie Pharmaceuticals $18.78 / -0.42 (-2.19%) 11/09/20 H.C. Wainwright Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright 10/28/20 H.C. Wainwright Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright 10/19/20 BofA Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA 10/19/20 BofA Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA ALDX Aldeyra $11.17 / +0.01 (+0.09%) 02/08/21 H.C. Wainwright Aldeyra initiated with a Buy at H.C. Wainwright 01/28/21 JonesTrading Aldeyra assumed with a Buy at JonesTrading 01/08/21 Jefferies Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies 01/08/21 Citi Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi ADVM UBX AGTC JNJ MGTX BIIB AERI ALDX ADVM Adverum Biotechnologies $11.12 / +0.13 (+1.18%) 03/01/21 Adverum Biotechnologies reports Q4 EPS (39c), consensus (32c) 11/05/20 Adverum Biotechnologies reports Q3 EPS (31c), consensus (34c) UBX Unity Biotechnology $6.17 / -0.58 (-8.59%) 11/04/20 Unity Biotechnology reports Q3 EPS (52c), consensus (49c) AGTC Applied Genetic $4.89 / -0.16 (-3.17%) 02/11/21 Applied Genetic reports Q4 EPS (60c), consensus (59c) 11/16/20 Applied Genetic reports Q4 EPS (60c), consensus (53c) 09/09/20 Applied Genetic reports Q4 EPS (56c), consensus (48c) JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MGTX MeiraGTx $14.54 / +0.6 (+4.30%) 11/05/20 MeiraGTx reports Q3 EPS (17c), consensus (70c) 10/28/20 MeiraGTx to present data on phase 1/2 clinical trial on AAV-RPGR BIIB Biogen $270.57 / +7.08 (+2.69%) 02/03/21 Biogen sees FY21 adjusted EPS $17.00-$18.50, consensus $24.67 02/03/21 Biogen reports Q4 adjusted EPS $4.58, consensus $4.87 02/02/21 Notable companies reporting before tomorrow's open 02/02/21 Notable companies reporting before tomorrow's open AERI Aerie Pharmaceuticals $18.78 / -0.42 (-2.19%) 02/25/21 Aerie Pharmaceuticals reports Q4 EPS (79c), consensus (73c) 11/05/20 Aerie Pharmaceuticals reports Q3 EPS (86c), consensus (80c) ALDX Aldeyra $11.17 / +0.01 (+0.09%) 11/05/20 Aldeyra reports Q3 EPS (23c), consensus (27c) 28 Jan 14 Jan 19 Nov 13 Aug JNJ BIIB JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 03/05/21 J&J COVID-19 vaccine approved by Canada's regulator, AP reports 03/03/21 American, United to give J&J COVID-19 vaccine to Chicago workers, Reuters says 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 03/02/21 IPG Mediabrands planning event focused on Black-owned media firms, AdAge says BIIB Biogen $270.57 / +7.08 (+2.69%) 11/07/20 Biogen Alzheimer's drug closer to approval, still not a buy, Barron's says 11/07/20 FDA may find it 'extremely' hard to approve Biogen drug after panel, STAT says 09/28/20 Biogen loses appeal in fight seeking royalties from Merck KGaA, Bloomberg says 09/28/20 Biogen loses appeal ruling on MS drug Rebif, Bloomberg says UBX AGTC JNJ BIIB AERI ALDX UBX Unity Biotechnology $6.17 / -0.58 (-8.59%) 09/16/20 Fly Intel: After-Hours Movers AGTC Applied Genetic $4.89 / -0.16 (-3.17%) 11/11/20 Hilton upgrade, AIG downgrade among today's top calls on Wall Street JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 03/05/21 Fly Intel: Wall Street's top stories for Friday 03/05/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday BIIB Biogen $270.57 / +7.08 (+2.69%) 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: Pre-market Movers 01/29/21 Fly Intel: Wall Street's top stories for Friday AERI Aerie Pharmaceuticals $18.78 / -0.42 (-2.19%) 10/19/20 Fly Intel: Wall Street's top stories for Monday 10/19/20 Fly Intel: Wall Street's top stories at midday 09/15/20 Fly Intel: Pre-market Movers ALDX Aldeyra $11.17 / +0.01 (+0.09%) 01/25/21 Fly Insider: OncoCyte, Air Transport among week's notable insider trades 01/21/21 Fly Intel: After-Hours Movers 13:00 Today Biopharmaceuticals 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/11/21 Aldeyra - ALDX 04/20/21 Johnson & Johnson - JNJ 06/07/21 PDUFA Date for Aducanumab BIIB BIIB Biogen $270.57 / +7.08 (+2.69%) 09/15/20 Alexion strength attributed to takeover speculation JNJ BIIB JNJ Johnson & Johnson $156.09 / +3.09 (+2.02%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th BIIB Biogen $270.57 / +7.08 (+2.69%) 01/29/21 Early notable gainers among liquid option names on January 29th 01/08/21 Biogen put volume heavy and directionally bearish 11/11/20 Early notable gainers among liquid option names on November 11th 11/05/20 Unusually active option classes on open November 5th

Conference/Events	Pinnacle West management to meet virtually with Mizuho » 04:55 03/08/21 03/08 04:55 03/08/21 04:55 PNW Pinnacle West $76.36 / +1.71 (+2.29%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PNW Pinnacle West $76.36 / +1.71 (+2.29%) 12/16/20 Nikola plans deal with Pinnacle West unit for energy in Arizona, Bloomberg says 10/22/20 Pinnacle West raises quarterly dividend 6.1% to 83c per share PNW Pinnacle West $76.36 / +1.71 (+2.29%) 02/25/21 Credit Suisse Pinnacle West downgraded to Neutral from Outperform at Credit Suisse 01/19/21 Credit Suisse Pinnacle West price target lowered to $86 from $92 at Credit Suisse 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 11/18/20 Barclays Pinnacle West price target raised to $103 from $89 at Barclays PNW Pinnacle West $76.36 / +1.71 (+2.29%) 02/24/21 Pinnacle West reports Q4 EPS (17c), consensus 4c 10/30/20 Pinnacle West raises FY20 EPS view to $4.95-$5.15 from $4.75-$4.95 10/30/20 Pinnacle West reports Q3 EPS $3.07, consensus $2.85 PNW Pinnacle West $76.36 / +1.71 (+2.29%) 12/16/20 Nikola planning to buy cheap power in Arizona to make hydrogen, Bloomberg says PNW Pinnacle West $76.36 / +1.71 (+2.29%) 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 00:00 Today Pinnacle West 03/09/21 Pinnacle West 12/06/21 Pinnacle West
Upgrade	Amneal Pharmaceuticals upgraded to Buy from Sell at Goldman Sachs » 04:54 03/08/21 03/08 04:54 03/08/21 04:54 AMRX Amneal Pharmaceuticals $4.95 / +0.13 (+2.70%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AMRX Amneal Pharmaceuticals $4.95 / +0.13 (+2.70%) 02/26/21 Amneal Pharmaceuticals receives ANDA approval for generic version of Ortho Evra 02/26/21 Amneal Pharmaceuticals sees FY21 operating cash flow $220M-$250M 01/12/21 Amneal Pharmaceuticals to acquire substantially all assets of Kashiv Specialty 01/08/21 Amneal Pharmaceuticals launches generic Abiraterone Acetate Tablets AMRX Amneal Pharmaceuticals $4.95 / +0.13 (+2.70%) 03/01/21 Barclays Amneal Pharmaceuticals price target raised to $8 from $6 at Barclays 12/14/20 Guggenheim Amneal Pharmaceuticals upgraded to Buy from Neutral at Guggenheim 12/14/20 Barclays Amneal upgraded to Overweight on generic recovery at Barclays 12/14/20 Barclays Amneal upgraded to Overweight from Equal Weight at Barclays AMRX Amneal Pharmaceuticals $4.95 / +0.13 (+2.70%) 02/26/21 Amneal Pharmaceuticals sees FY21 adjusted EPS 70c-85c, consensus 71c 02/26/21 Amneal Pharmaceuticals reports Q4 adjusted EPS 14c, consensus 13c 11/06/20 Amneal Pharmaceuticals raises FY20 adj. EPS view to 55c-65c from 45c-60c 11/06/20 Amneal Pharmaceuticals reports Q3 adjusted EPS 16c, consensus 12c
Downgrade	Viatris downgraded to Neutral from Buy at Goldman Sachs » 04:52 03/08/21 03/08 04:52 03/08/21 04:52 VTRS Viatris $13.91 / +0.31 (+2.28%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options VTRS Viatris $13.91 / +0.31 (+2.28%) 03/03/21 U.S. District Court rules in AstraZeneca's favor in Symbicort patent litigation 02/22/21 Viatris to initiate 11c per share quarterly dividend in May 01/28/21 FTC approves final order on Pfizer, Mylan deal with conditions 12/21/20 Mapi Pharma provides enrollment update on Phase III GA Depot trial VTRS Viatris $13.91 / +0.31 (+2.28%) 03/02/21 JPMorgan Viatris downgraded to Neutral on 'modest' growth at JPMorgan 03/02/21 JPMorgan Viatris downgraded to Neutral from Overweight at JPMorgan 02/26/21 Wolfe Research Viatris downgraded to Peer Perform from Outperform at Wolfe Research 02/23/21 Barclays Viatris price target lowered to $20 from $26 at Barclays VTRS Viatris $13.91 / +0.31 (+2.28%) 02/22/21 Viatris sees FY21 revenue $17.2B-$17.8B, consensus $18.46B VTRS Viatris $13.91 / +0.31 (+2.28%) 03/02/21 Viatris put volume heavy and directionally bearish 02/19/21 Viatris call volume above normal and directionally bullish 02/08/21 Viatris put volume heavy and directionally bearish 01/14/21 Viatris call volume above normal and directionally bullish
Initiation	Signify Health initiated with an Overweight at Piper Sandler » 04:50 03/08/21 03/08 04:50 03/08/21 04:50 SGFY Signify Health $28.30 / +0.57 (+2.06%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Syndicate On The Fly Options 11 Feb SGFY Signify Health $28.30 / +0.57 (+2.06%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts SGFY Signify Health $28.30 / +0.57 (+2.06%) 02/26/21 Eleven new option listings on February 26th
Initiation	Apria initiated with an Overweight at Piper Sandler » 04:48 03/08/21 03/08 04:48 03/08/21 04:48 APR Apria $21.49 / -0.41 (-1.87%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Syndicate On The Fly APR Apria $21.49 / -0.41 (-1.87%) 02/25/21 Apria names Michael-Bryant Hicks as EVP, general counsel 11 Feb APR Apria $21.49 / -0.41 (-1.87%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech

Events

Earnings calls, analyst events, roadshows and more

NIU
Today at 08:00

Niu Technologies - NIU Conference Calls
XPEV
Today at 08:00

Xpeng - XPEV Conference Calls
NERV
Today at 08:30

Minerva - NERV Conference Calls
CI
Today at 08:30

CIGNA Corporation Firm Sponsored Meetings
ABCM
Today at 09:00

Abcam - ABCM Conference Calls
Today at 10:00

Wholesale Inventories (Preliminary) M/M: January 2021 Government Event
FOLD
Today at 10:00

Amicus - FOLD Conference Calls
NINE
Today at 10:00

Nine Energy Service - NINE Conference Calls
MGIC
Today at 10:00

Magic Software - MGIC Conference Calls
PERI
Today at 10:00

Perion Network Ltd. Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CPNG X CPNG Coupang IPO Managers: Goldman Sachs, Allen & Co., JPMorgan & BofA, HSBC, Deutsche Bank, UBS, MIZU, CLSA $27.00-30.00 120M Shares GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HAYW X HAYW Hayward IPO Managers: BofA, Goldman Sachs & Nomura, Credit Suisse, Morgan Stanley, Baird, Guggenheim, Jefferies, BMO Capital, KeyBanc, William Blair, HOUL, Moelis $17.00-19.00 40.278M Shares
Thurs	JOAN X JOAN Joann IPO Managers: BofA & Credit Suisse, Guggenheim, Barclays, Wells Fargo, Piper Sandler, William Blair, HOUL, Telsey Advisory, Loop Capital, Ramirez $15.00-17.00 10.94M Shares
Fri	No deals

View All Syndicate Announcements »

Software AG price target lowered to EUR 35 from EUR 37 at JPMorgan

TODAY'S FREE FLY STORIES

Get Full Fly Access